273 related articles for article (PubMed ID: 27563888)
1. Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.
Li D; Han T; Liao J; Hu X; Xu S; Tian K; Gu X; Cheng K; Li Z; Hua H; Xu J
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563888
[TBL] [Abstract][Full Text] [Related]
2. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
3. Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells.
Dal Piaz F; Cotugno R; Lepore L; Vassallo A; Malafronte N; Lauro G; Bifulco G; Belisario MA; De Tommasi N
J Proteomics; 2013 Apr; 82():14-26. PubMed ID: 23416714
[TBL] [Abstract][Full Text] [Related]
4. Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao.
Li D; Han T; Xu S; Zhou T; Tian K; Hu X; Cheng K; Li Z; Hua H; Xu J
Molecules; 2016 Apr; 21(5):. PubMed ID: 27144553
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
6. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S
Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
8. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
9. Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.
Ding C; Zhang Y; Chen H; Yang Z; Wild C; Chu L; Liu H; Shen Q; Zhou J
J Med Chem; 2013 Jun; 56(12):5048-58. PubMed ID: 23746196
[TBL] [Abstract][Full Text] [Related]
10. Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities.
Cheng W; Huang C; Ma W; Tian X; Zhang X
Mini Rev Med Chem; 2019; 19(2):114-124. PubMed ID: 28425866
[TBL] [Abstract][Full Text] [Related]
11. Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria.
Xu S; Luo S; Yao H; Cai H; Miao X; Wu F; Yang DH; Wu X; Xie W; Yao H; Chen ZS; Xu J
J Med Chem; 2016 May; 59(10):5022-34. PubMed ID: 27089099
[TBL] [Abstract][Full Text] [Related]
12. Induction of the mitochondria-mediated apoptosis in human esophageal cancer cells by DS2, a newly synthetic diterpenoid analog, is regulated by Bax and caused by generation of reactive oxygen species.
Ma YC; Ke Y; Zi X; Zhao F; Yuan L; Zhu YL; Fan XX; Zhao NM; Li QY; Qin YH; Liu HM
Oncotarget; 2016 Dec; 7(52):86211-86224. PubMed ID: 27863415
[TBL] [Abstract][Full Text] [Related]
13. Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.
Wang M; Li H; Xu F; Gao X; Li J; Xu S; Zhang D; Wu X; Xu J; Hua H; Li D
Eur J Med Chem; 2018 Aug; 156():885-906. PubMed ID: 30059803
[TBL] [Abstract][Full Text] [Related]
14. A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway.
Xu S; Yao H; Luo S; Zhang YK; Yang DH; Li D; Wang G; Hu M; Qiu Y; Wu X; Yao H; Xie W; Chen ZS; Xu J
J Med Chem; 2017 Feb; 60(4):1449-1468. PubMed ID: 28165738
[TBL] [Abstract][Full Text] [Related]
15. 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents.
Xu S; Yao H; Hu M; Li D; Zhu Z; Xie W; Yao H; Wu L; Chen ZS; Xu J
J Nat Prod; 2017 Sep; 80(9):2391-2398. PubMed ID: 28901767
[TBL] [Abstract][Full Text] [Related]
16. Ent-kaurane diterpenoids from Isodon rubescens var. lushanensis.
Han QB; Li ML; Li SH; Mou YK; Lin ZW; Sun HD
Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):790-3. PubMed ID: 12843583
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin.
Tian W; Chen SY
Chin J Integr Med; 2013 Apr; 19(4):315-20. PubMed ID: 23546635
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer
Sarwar MS; Xia YX; Liang ZM; Tsang SW; Zhang HJ
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963204
[TBL] [Abstract][Full Text] [Related]
19. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling.
Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM
Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and cellular localization study of fluorescent derivatives of Jiyuan Oridonin A.
Zhou C; Zhang JY; Liu HB; Tian XY; Liu Y; Wang YL; Zheng ZJ; Wang N; Wang ZJ; Xu X; Liu HM; Ke Y
Eur J Med Chem; 2022 Feb; 229():114048. PubMed ID: 34954589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]